Ramipril HCT Zentiva 2.5/12.5 mg
Ramipril HCT Zentiva 2.5/12.5 mg is a medicine authorised by Swissmedic under authorisation number 58177. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 May 2007 and the authorisation is valid without a time limit. ATC code C09BA05 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 58177 |
|---|---|
| Name | Ramipril HCT Zentiva 2.5/12.5 mg |
| Full name | Ramipril HCT Zentiva 2.5/12.5 mg, Tabletten |
| Authorisation holder | Helvepharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09BA05 |
| First authorisation | 07 May 2007 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ramipril HCT Zentiva 2.5/12.5 mg, Tabletten | B | 07 May 2007 |
| 2 | Ramipril HCT Zentiva 5/25 mg, Tabletten | B | 07 May 2007 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 9 | 20 | Tablette(n) | C09BA05 | 02.07.2. | B |
| 10 | 100 | Tablette(n) | C09BA05 | 02.07.2. | B |
| 11 | 20 | Tablette(n) | C09BA05 | 02.07.2. | B |
| 12 | 100 | Tablette(n) | C09BA05 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ramipril HCT Zentiva 2.5/12.5 mg authorised in Switzerland?
Yes. Ramipril HCT Zentiva 2.5/12.5 mg is authorised by Swissmedic under authorisation number 58177, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ramipril HCT Zentiva 2.5/12.5 mg have?
Ramipril HCT Zentiva 2.5/12.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ramipril HCT Zentiva 2.5/12.5 mg?
The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.